In another study, Esfandi et al. (2019) reported diagnostic power of 75% for BACE1-AS in 30 patients with gastric cancer, while Yeganeh et al. (2020) also reported that increased expression of BACE1-AS along with 4 other lncRNAs in 30 tissues of breast cancer suggested them as potential biomarkers for breast cancer. This evidence concerns the gene BACE1 and gastric cancer.